Related references
Note: Only part of the references are listed.CBTp for people with treatment refractory schizophrenia on clozapine: a systematic review and meta-analysis
Aleksandar Todorovic et al.
JOURNAL OF MENTAL HEALTH (2023)
Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study
Jose M. Rubio et al.
PSYCHOLOGICAL MEDICINE (2020)
Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia
Robin Emsley et al.
SCHIZOPHRENIA RESEARCH (2020)
The clinical course of schizophrenia in women and men-a nation-wide cohort study
Iris E. Sommer et al.
NPJ SCHIZOPHRENIA (2020)
Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1-12.5 Years
Jentien M. Vermeulen et al.
SCHIZOPHRENIA BULLETIN (2019)
PREDICTING TREATMENT RESISTANT SCHIZOPHRENIA AT FIRST-EPISODE OF PSYCHOSIS
Sophie Smart et al.
SCHIZOPHRENIA BULLETIN (2019)
Predictors of remission during acute treatment of first-episode schizophrenia patients involuntarily hospitalized and treated with algorithm-based pharmacotherapy: Secondary analysis of an observational study
Bunta Yoshimura et al.
EARLY INTERVENTION IN PSYCHIATRY (2019)
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
Joseph Firth et al.
LANCET PSYCHIATRY (2019)
Prescriber and institutional barriers and facilitators of clozapine use: A systematic review
Helene Verdoux et al.
SCHIZOPHRENIA RESEARCH (2018)
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
Rene S. Kahn et al.
LANCET PSYCHIATRY (2018)
Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis
D. J. Siskind et al.
EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES (2017)
Clozapine Use in a Cohort of First-Episode Psychosis
Roisin Doyle et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
A. Demjaha et al.
PSYCHOLOGICAL MEDICINE (2017)
International trends in clozapine use: a study in 17 countries
C. J. Bachmann et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
The impact of clozapine on hospital use: a systematic review and meta-analysis
R. Land et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Clozapine V. first-and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis
Dan Siskind et al.
BRITISH JOURNAL OF PSYCHIATRY (2016)
Correlates of Clozapine Use after a First Episode of Schizophrenia: Results From a Long-term Prospective Study
Alp Ucok et al.
CNS DRUGS (2016)
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones
Felice Iasevoli et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses
J. Lally et al.
PSYCHOLOGICAL MEDICINE (2016)
Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study
Theresa Wimberley et al.
LANCET PSYCHIATRY (2016)
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review
James L. Kennedy et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2014)
Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials
Taishiro Kishimoto et al.
SCHIZOPHRENIA BULLETIN (2014)
A domains-based taxonomy of supported accommodation for people with severe and persistent mental illness
Dan Siskind et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2013)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
Alkomiet Hasan et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2013)
Insight, psychopathology, explanatory models and outcome of schizophrenia in India: a prospective 5-year cohort study
Shanthi Johnson et al.
BMC PSYCHIATRY (2012)
Personalised support delivered by support workers for people with severe and persistent mental illness: a systematic review of patient outcomes
D. Siskind et al.
EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES (2012)
An Algorithm-Based Approach to First-Episode Schizophrenia: Response Rates Over 3 Prospective Antipsychotic Trials With a Retrospective Data Analysis
Ofer Agid et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study
A Malla et al.
PSYCHOLOGICAL MEDICINE (2006)
A systematic review of the prevalence of schizophrenia
S Saha et al.
PLOS MEDICINE (2005)
Sex differences in the risk of schizophrenia - Evidence from meta-analysis
A Aleman et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
